PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration. | 37645752 | Sans M, Chen Y, Thege FI, Dou R, Min J, Yip-Schneider M, Zhang J, Wu R, Irajizad E, Makino Y, Rajapakshe KI, Hurd MW, León-Letelier RA, Vykoukal J, Dennison JB, Do KA, Wolff RA, Guerrero PA, Kim MP, Schmidt CM, Maitra A, Hanash S, Fahrmann JF | bioRxiv | 2023 | PLCO |
| Estimation and inference of predictive discrimination for survival outcome risk prediction models. | 35061146 | Li R, Ning J, Feng Z | Lifetime Data Anal | 2022 | PLCO |
| Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. | 34995129 | Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM | J Clin Oncol | 2022 | PLCO |
| Inflammatory potential of diet and colorectal carcinogenesis: a prospective longitudinal cohort. | 35136208 | Li Z, Wang K, Shivappa N, Hébert JR, Chen H, Liu H, Jiang X | Br J Cancer | 2022 | PLCO |
| Weight Change and Incident Distal Colorectal Adenoma Risk in the PLCO Cancer Screening Trial. | 35112050 | He S, Berndt SI, Kunzmann AT, Kitahara CM, Huang WY, Barry KH | JNCI Cancer Spectr | 2022 | PLCO |
| Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. | 35113855 | Yarmolinsky J, Díez-Obrero V, Richardson TG, Pigeyre M, Sjaarda J, Paré G, Walker VM, Vincent EE, Tan VY, Obón-Santacana M, Albanes D, Hampe J, Gsur A, Hampel H, Pai RK, Jenkins M, Gallinger S, Casey G, Zheng W, Amos CI, International Lung Cancer Co… | PLoS Med | 2022 | PLCO |
| Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. | 35048991 | Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, Tsilidis KK, Barroso I, Chen J, Frayling TM, Bull CJ, Vincent EE, Cotterchio M, Gruber SB, Pai RK, Newcomb PA, Perez-Cornago A, van Duijnhoven FJB, Van Guelpen B, Vodicka… | J Natl Cancer Inst | 2022 | PLCO |
| Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials. | 35351104 | Gelfond JA, Hernandez B, Goros M, Ibrahim JG, Chen MH, Sun W, Leach RJ, Kattan MW, Thompson IM, Ankerst DP, Liss M | BMC Urol | 2022 | PLCO |
| IPRS: Leveraging Gene-Environment Interaction to Reconstruct Polygenic Risk Score. | 35401709 | Tang Y, You D, Yi H, Yang S, Zhao Y | Front Genet | 2022 | PLCO |
| Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. | 35365600 | Chang VC, Khan AA, Huang WY, Katki HA, Purdue MP, Landgren O, Hofmann JN | Blood Cancer J | 2022 | PLCO |
| Alu Retroelement Copy Number and Lung Cancer Risk in the Prospective Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | 35609672 | Wong JYY , Cawthon R , Hu W , Ezennia S , Gadalla SM , Breeze C , Blechter B , Freedman ND , Huang WY , Hosgood HD , Seow WJ , Bassig BA , Rahman ML , Hayes RB , Rothman N , Lan Q | Chest | 2022 | PLCO |
| Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer. | 35583137 | Loftfield E, Falk RT, Sampson JN, Huang WY, Hullings A, Murphy G, Weinstein SJ, Albanes D, Freedman ND, Sinha R | JNCI Cancer Spectr | 2022 | PLCO |
| Association Between Diabetes Risk Reduction Diet and Lung Cancer Risk in 98,159 Participants: Results From a Prospective Study. | 35574372 | Zhang Y, Zhong G, Zhu M, Chen L, Wan H, Luo F | Front Oncol | 2022 | PLCO |
| Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. | 35534235 | In H, Sarkar S, Ward J, Friedmann P, Parides M, Yang J, Epplein M | Cancer Epidemiol Biomarkers Prev | 2022 | PLCO |
| Genetic variants in DDO and PEX5L in peroxisome-related pathways predict non-small cell lung cancer survival. | 35502931 | Chen AS, Liu H, Wu Y, Luo S, Patz EF, Glass C, Su L, Du M, Christiani DC, Wei Q | Mol Carcinog | 2022 | PLCO |
| The Intervention Probability Curve: Modeling the Practical Application of Threshold-Guided Decision-Making, Evaluated in Lung, Prostate, and Ovarian Cancers. | 35732292 | Kammer MN, Rowe DJ, Deppen SA, Grogan EL, Kaizer AM, Barón AE, Maldonado F | Cancer Epidemiol Biomarkers Prev | 2022 | NLST, PLCO |
| Sweetened beverage consumption and risk of liver cancer by diabetes status: A pooled analysis. | 35728406 | Jones GS, Graubard BI, Ramirez Y, Liao LM, Huang WY, Alvarez CS, Yang W, Zhang X, Petrick JL, McGlynn KA | Cancer Epidemiol | 2022 | PLCO |
| Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study. | 35658861 | You D, Wang D, Wu Y, Chen X, Shao F, Wei Y, Zhang R, Lange T, Ma H, Xu H, Hu Z, Christiani DC, Shen H, Chen F, Zhao Y | BMC Med | 2022 | PLCO |
| Impact of Comorbidities on Lung Cancer Screening Evaluation. | 35641376 | Robinson EM, Liu BY, Sigel K, Yin C, Wisnivesky J, Kale MS | Clin Lung Cancer | 2022 | PLCO |
| PLCOjs, a FAIR GWAS web SDK for the NCI Prostate, Lung, Colorectal and Ovarian Cancer Genetic Atlas project. | 35900159 | Ruan E , Nemeth E , Moffitt R , Sandoval L , Machiela MJ , Freedman ND , Huang WY , Wong W , Chen KL , Park B , Jiang K , Hicks B , Liu J , Russ D , Minasian L , Pinsky P , Chanock SJ , Garcia-Closas M , Almeida JS | Bioinformatics | 2022 | PLCO |